AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.
Our previous study found that thyroid-stimulating hormone promoted sterol regulatory element-binding protein-2 (SREBP-2) expression and suppressed AMP-activated protein kinase (AMPK) activity in the liver, but it was unclear whether there was a direct link between TSH, AMPK and SREBP-2. Here, we dem...
Main Authors: | Shudong Liu, Fei Jing, Chunxiao Yu, Ling Gao, Yejun Qin, Jiajun Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4416759?pdf=render |
Similar Items
-
Hypolipidemic properties of Chlorella pyrenoidosa organic acids via AMPK/HMGCR/SREBP‐1c pathway in vivo
by: Jie Chen, et al.
Published: (2021-01-01) -
Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing[S]
by: Liang Chen, et al.
Published: (2019-10-01) -
AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats
by: Haoyang Zhu, et al.
Published: (2018-01-01) -
TSH promotes adiposity by inhibiting the browning of white fat
by: Jianmei Zhang, et al.
Published: (2020-01-01) -
Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver
by: Eun-Jeong Jung, et al.
Published: (2011-09-01)